Find out why testing for anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies is recommended for differential diagnosis.
Head and neck pathology at Mayo Clinic Laboratories
Head and neck pathology consultations often relate to the classification of salivary, sinonasal, and oropharynx tumors.Check out Mayo Clinic Laboratories’ head and neck pathology section, which is integrated with the clinical practice at...
New tests launched in September - Insights
In September 2022, Mayo Clinic Laboratories announced ten new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
New tests launched in November - Insights
Mayo Clinic Laboratories launched the following three tests in November.
Prostate Health Index (phi) [Test in Focus] - Insights
Useful For Assessing the patient’s probability of having detectable prostate cancer when totalprostate specific antigen (PSA) concentrations are between
Chromium and Cobalt Testing [Test in Focus] - Insights
Chromium and cobalt blood tests are used to monitor exposure to these elements. Both of these elements are naturally occurring and widely distributed in the environment. Previously, serum samples were collected and used to monitor patients...
Alpha-gal testing [Test in Focus] - Insights
Joshua Bornhorst, Ph.D., associate director of Mayo Clinic's Clinical Immunoassay Lab, explains how humans can develop an allergy to the alpha-gal molecule, and he describes a new allergen antibody test that can be used to detect it. Dr....
Case Studies in Laboratory Safety - Insights
PACEThis webinar will provide a review of several real-life laboratory safety events. The presentation will outline the scenarios, the lessons learned and look at ways future incidents can be prevented. We will also discuss ways to create...
MDM2 gene amplification [Test in Focus] - Insights
William Sukov, M.D., provides an overview of the MDM2 gene amplification assay — a test that looks for amplification of the MDM2 gene region on chromosome 12q. He reviews when this test should be ordered, how it compares to other test...
B-cell lymphoblastic leukemia monitoring for minimal residual disease [Test in Focus] - Insights
Min Shi, M.D., Ph.D., a hematologist and co-director of Mayo Clinic's Flow Cytometry Laboratory, explains recent updates to the B-cell lymphoblastic leukemia minimal residual disease flow cytometry assay. This test is used to identify...